title: Debates in allergy medicine: specific immunotherapy efficiency in children with atopic dermatitis.
abstract: Allergen specific immunotherapy (AIT) has been the only pathogenetically relevant treatment of IgE-mediated allergic diseases (ADs) for many years. The use of AIT for atopic dermatitis (AD) treatment is dubious and has both followers and opponents. The improvement of subcutaneous AIT (SCIT) and introduction of Sublingual immunotherapy (SLIT) gives prospects of their application both for adults and children suffering from AD. This review presents results of scientific research, system and meta-analyses that confirm the clinical efficacy of AIT for children with AD who has the sensitization to allergens of house dust mite, grass and plant pollen suffering from co-occurring respiratory ADs and with moderate and severe course of allergic AD. There have been analyzed the most advanced achievements in AIT studies as well as there have been specified the unmet needs in AD. The preliminary diagnostics of IgE-mediated AD and pathophysiological disorders, including immune ones, will allow a doctor to develop appropriate comprehensive treatment algorithm for children's AD aimed at its correction. The including of AIT to the children's comprehensive therapy program is reasonable only if AD has the allergic form. It is necessary better to design the randomized research studies and to acquire extended clinical practice in children with AD. Use of the successes of molecular-based allergy diagnostics will help to optimize and personalize the process of selecting the necessary allergens to determine the most appropriate vaccines for children considering the results of the allergen component diagnostics. The strategy of treatment of children with AD in future will be based on individual target therapy.
authors.affiliation: People's Friendship University of Russia, Moscow, Moscow region Russia ; Institute of Immunophysiology, Moscow, Russia.
authors.forename: Tatiana A
authors.initials: TA
authors.lastname: Slavyanakaya
authors.affiliation: Institute of Immunophysiology, Moscow, Russia ; Pacific State Medical University, Vladivostok, Russia.
authors.forename: Vladislava V
authors.initials: VV
authors.lastname: Derkach
authors.affiliation: People's Friendship University of Russia, Moscow, Moscow region Russia ; Institute of Immunophysiology, Moscow, Russia.
authors.forename: Revaz I
authors.initials: RI
authors.lastname: Sepiashvili
keywords: Aeroallergen; Allergen specific immunotherapy; Atopic dermatitis; Children; Clinical efficacy; Subcutaneous specific immunotherapy; Sublingual specific immunotherapy